Why the study?
Does laser thrombolysis improve TIMI flow and is it safe in patients with acute myocardial infarction who are ineligible for or failed fibrinolytic therapy?
Does laser thrombolysis improve TIMI flow and is it safe in patients with acute myocardial infarction who are ineligible for or failed fibrinolytic therapy?
Laser thrombolysis is a feasible and safe concept for improving coronary flow in acute myocardial infarction, but it requires substantial catheter improvements and is not an effective stand-alone therapy.
Answers are grounded in this paper and cite their sources.
Does not support laser thrombolysis as stand-alone AMI therapy; hypothesis-generating for catheter refinement in flow restoration.
Laser thrombolysis is a new, experimental, catheter based intervention aimed at selectively removing intracoronary thrombus. This first clinical study was performed to assess the feasibility and safety of laser thrombolysis, as well as its potential therapeutic place in acute myocardial infarction. Eighteen patients with acute myocardial infarction, who were either noncandidates for, or failures on, intravenous fibrinolytic therapy were included for treatment with laser thrombolysis followed by balloon angioplasty. As a result of catheter and technical failures, the laser was actually fired in only 12 patients. Improvement in TIMI flow from grade 0-1 to grade 2-3 was observed in 10 of these 12 patients after laser application. The overall results of 18 patients were: increase in TIMI grade flow from 0.33 +/- 0.49 after wire passage to 1.28 +/- 1.23 (P = 0.0051) after attempted laser application, and to 2.67 +/- 0.97 after PTCA (P = 0.0004). Two patients with previous infarctions died from left ventricular failure despite successful laser thrombolysis. One patient died during emergency bypass surgery after a failed recanalization attempt. Perforation or laser related dissection did not occur. The concept of selective laser thrombus ablation seems to be safe and feasible, but substantial improvements of the laser delivery catheters are needed. Laser thrombolysis is not an effective stand-alone therapy in acute myocardial infarction, but other possible applications warrant further research and development efforts for this potentially useful interventional tool.
No takes yet. Share an insight, caveat, or question.
Heijer et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: